-
1
-
-
80053285992
-
Worldwide burden of cervical cancer in 2008
-
Arbyn M, Castellsague X, de Sanjose S, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol 2011; 22:2675–86.
-
(2011)
Ann Oncol
, vol.22
, pp. 2675-2686
-
-
Arbyn, M.1
Castellsague, X.2
de Sanjose, S.3
-
2
-
-
84883554720
-
Human papillomavirus and cervical cancer
-
Crosbie EJ, Einstein MH, Franceschi S, et al. Human papillomavirus and cervical cancer. Lancet 2013; 382:889–99.
-
(2013)
Lancet
, vol.382
, pp. 889-899
-
-
Crosbie, E.J.1
Einstein, M.H.2
Franceschi, S.3
-
3
-
-
0024428508
-
The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes
-
Munger K, Phelps WC, Bubb V, et al. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 1989; 63:4417–21.
-
(1989)
J Virol
, vol.63
, pp. 4417-4421
-
-
Munger, K.1
Phelps, W.C.2
Bubb, V.3
-
4
-
-
12544257675
-
Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein
-
Preville X, Ladant D, Timmerman B, et al. Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein. Cancer Res 2005; 65:641–9.
-
(2005)
Cancer Res
, vol.65
, pp. 641-649
-
-
Preville, X.1
Ladant, D.2
Timmerman, B.3
-
5
-
-
34548731406
-
Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system
-
Berraondo P, Nouze C, Preville X, et al. Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system. Cancer Res 2007; 67:8847–55.
-
(2007)
Cancer Res
, vol.67
, pp. 8847-8855
-
-
Berraondo, P.1
Nouze, C.2
Preville, X.3
-
6
-
-
79952697696
-
B-lymphocyte effector functions in health and disease
-
DiLillo DJ, Horikawa M, Tedder TF. B-lymphocyte effector functions in health and disease. Immunol Res 2011; 49:281–92.
-
(2011)
Immunol Res
, vol.49
, pp. 281-292
-
-
DiLillo, D.J.1
Horikawa, M.2
Tedder, T.F.3
-
7
-
-
77950070632
-
Effector and regulatory B cells: modulators of CD4+ T cell immunity
-
Lund FE, Randall TD. Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nat Rev Immunol 2010; 10:236–47.
-
(2010)
Nat Rev Immunol
, vol.10
, pp. 236-247
-
-
Lund, F.E.1
Randall, T.D.2
-
8
-
-
78650219406
-
Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection
-
Neves P, Lampropoulou V, Calderon-Gomez E, et al. Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 2010; 33:777–90.
-
(2010)
Immunity
, vol.33
, pp. 777-790
-
-
Neves, P.1
Lampropoulou, V.2
Calderon-Gomez, E.3
-
9
-
-
16544381960
-
Regulatory roles for cytokine-producing B cells in infection and autoimmune disease
-
Lund FE, Garvy BA, Randall TD, et al. Regulatory roles for cytokine-producing B cells in infection and autoimmune disease. Curr Dir Autoimmun 2005; 8:25–54.
-
(2005)
Curr Dir Autoimmun
, vol.8
, pp. 25-54
-
-
Lund, F.E.1
Garvy, B.A.2
Randall, T.D.3
-
10
-
-
84928177138
-
Regulatory B cells: origin, phenotype, and function
-
Rosser EC, Mauri C. Regulatory B cells: origin, phenotype, and function. Immunity 2015; 42:607–12.
-
(2015)
Immunity
, vol.42
, pp. 607-612
-
-
Rosser, E.C.1
Mauri, C.2
-
11
-
-
0036197923
-
Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation
-
Mizoguchi A, Mizoguchi E, Takedatsu H, et al. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002; 16:219–30.
-
(2002)
Immunity
, vol.16
, pp. 219-230
-
-
Mizoguchi, A.1
Mizoguchi, E.2
Takedatsu, H.3
-
12
-
-
33747880415
-
Inhibitory effects of B cells on antitumor immunity
-
Inoue S, Leitner WW, Golding B, et al. Inhibitory effects of B cells on antitumor immunity. Cancer Res 2006; 66:7741–7.
-
(2006)
Cancer Res
, vol.66
, pp. 7741-7747
-
-
Inoue, S.1
Leitner, W.W.2
Golding, B.3
-
13
-
-
0018190839
-
Anti-tumor immunity in B lymphocyte-deprived mice. I. Immunity to a chemically induced tumor
-
Brodt P, Gordon J. Anti-tumor immunity in B lymphocyte-deprived mice. I. Immunity to a chemically induced tumor. J Immunol 1978; 121:359–62.
-
(1978)
J Immunol
, vol.121
, pp. 359-362
-
-
Brodt, P.1
Gordon, J.2
-
14
-
-
79956131523
-
Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4 T cells to T-regulatory cells
-
Olkhanud PB, Damdinsuren B, Bodogai M, et al. Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4 T cells to T-regulatory cells. Cancer Res 2011; 71:3505–15.
-
(2011)
Cancer Res
, vol.71
, pp. 3505-3515
-
-
Olkhanud, P.B.1
Damdinsuren, B.2
Bodogai, M.3
-
16
-
-
70149098555
-
Nonredundant roles for B cell-derived IL-10 in immune counter-regulation
-
Madan R, Demircik F, Surianarayanan S, et al. Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J Immunol 2009; 183:2312–20.
-
(2009)
J Immunol
, vol.183
, pp. 2312-2320
-
-
Madan, R.1
Demircik, F.2
Surianarayanan, S.3
-
17
-
-
0025852445
-
A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene
-
Kitamura D, Roes J, Kuhn R, et al. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 1991; 350:423–6.
-
(1991)
Nature
, vol.350
, pp. 423-426
-
-
Kitamura, D.1
Roes, J.2
Kuhn, R.3
-
18
-
-
0027521572
-
Interleukin-10-deficient mice develop chronic enterocolitis
-
Kuhn R, Lohler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75:263–74.
-
(1993)
Cell
, vol.75
, pp. 263-274
-
-
Kuhn, R.1
Lohler, J.2
Rennick, D.3
-
19
-
-
0030068375
-
Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen
-
Lin KY, Guarnieri FG, Staveley-O'Carroll KF, et al. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res 1996; 56:21–6.
-
(1996)
Cancer Res
, vol.56
, pp. 21-26
-
-
Lin, K.Y.1
Guarnieri, F.G.2
Staveley-O'Carroll, K.F.3
-
20
-
-
14044265394
-
Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction
-
Bustin SA, Nolan T. Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. J Biomol Tech 2004; 15:155–66.
-
(2004)
J Biomol Tech
, vol.15
, pp. 155-166
-
-
Bustin, S.A.1
Nolan, T.2
-
21
-
-
65449188259
-
Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice
-
Blair PA, Chavez-Rueda KA, Evans JG, et al. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol 2009; 182:3492–502.
-
(2009)
J Immunol
, vol.182
, pp. 3492-3502
-
-
Blair, P.A.1
Chavez-Rueda, K.A.2
Evans, J.G.3
-
22
-
-
84883441574
-
Peritoneal cavity regulatory B cells (B10 cells) modulate IFN-gamma+CD4+ T cell numbers during colitis development in mice
-
Maseda D, Candando KM, Smith SH, et al. Peritoneal cavity regulatory B cells (B10 cells) modulate IFN-gamma+CD4+ T cell numbers during colitis development in mice. J Immunol 2013; 191:2780–95.
-
(2013)
J Immunol
, vol.191
, pp. 2780-2795
-
-
Maseda, D.1
Candando, K.M.2
Smith, S.H.3
-
23
-
-
84930418220
-
PD-L1hi B cells are critical regulators of humoral immunity
-
Khan AR, Hams E, Floudas A, et al. PD-L1hi B cells are critical regulators of humoral immunity. Nat Commun 2015; 6:5997
-
(2015)
Nat Commun
, vol.6
, pp. 5997
-
-
Khan, A.R.1
Hams, E.2
Floudas, A.3
-
24
-
-
84883736768
-
Adenosine production by human B cells and B cell-mediated suppression of activated T cells
-
Saze Z, Schuler PJ, Hong CS, et al. Adenosine production by human B cells and B cell-mediated suppression of activated T cells. Blood 2013; 122:9–18.
-
(2013)
Blood
, vol.122
, pp. 9-18
-
-
Saze, Z.1
Schuler, P.J.2
Hong, C.S.3
-
25
-
-
0345414164
-
Activation induced differential regulation of stem cell antigen-1 (Ly-6A/E) expression in murine B cells
-
Chen HC, Frissora F, Durbin JE, et al. Activation induced differential regulation of stem cell antigen-1 (Ly-6A/E) expression in murine B cells. Cell Immunol 2003; 225:42–52.
-
(2003)
Cell Immunol
, vol.225
, pp. 42-52
-
-
Chen, H.C.1
Frissora, F.2
Durbin, J.E.3
-
26
-
-
0025038599
-
Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
-
Schall TJ, Bacon K, Toy KJ, et al. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990; 347:669–71.
-
(1990)
Nature
, vol.347
, pp. 669-671
-
-
Schall, T.J.1
Bacon, K.2
Toy, K.J.3
-
27
-
-
78650011822
-
A role for the B-cell CD74/macrophage migration inhibitory factor pathway in the immunomodulation of systemic lupus erythematosus by a therapeutic tolerogenic peptide
-
Lapter S, Ben-David H, Sharabi A, et al. A role for the B-cell CD74/macrophage migration inhibitory factor pathway in the immunomodulation of systemic lupus erythematosus by a therapeutic tolerogenic peptide. Immunology 2011; 132:87–95.
-
(2011)
Immunology
, vol.132
, pp. 87-95
-
-
Lapter, S.1
Ben-David, H.2
Sharabi, A.3
-
28
-
-
84859385739
-
Immune regulatory function of B cells
-
Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol 2012; 30:221–41.
-
(2012)
Annu Rev Immunol
, vol.30
, pp. 221-241
-
-
Mauri, C.1
Bosma, A.2
-
29
-
-
79952198828
-
Identifying regulatory B cells (B10 cells) that produce IL-10 in mice
-
Matsushita T, Tedder TF. Identifying regulatory B cells (B10 cells) that produce IL-10 in mice. Methods Mol Biol 2011; 677:99–111.
-
(2011)
Methods Mol Biol
, vol.677
, pp. 99-111
-
-
Matsushita, T.1
Tedder, T.F.2
-
30
-
-
33947632923
-
Inflammation, lymphatic function, and dendritic cell migration
-
Angeli V, Randolph GJ. Inflammation, lymphatic function, and dendritic cell migration. Lymphat Res Biol 2006; 4:217–28.
-
(2006)
Lymphat Res Biol
, vol.4
, pp. 217-228
-
-
Angeli, V.1
Randolph, G.J.2
-
31
-
-
84867900263
-
HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes
-
Girard JP, Moussion C, Forster R. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat Rev Immunol 2012; 12:762–73.
-
(2012)
Nat Rev Immunol
, vol.12
, pp. 762-773
-
-
Girard, J.P.1
Moussion, C.2
Forster, R.3
-
32
-
-
0034797926
-
Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer
-
Kakolyris S, Giatromanolaki A, Koukourakis M, et al. Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer. Clin Cancer Res 2001; 7:3087–91.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 3087-3091
-
-
Kakolyris, S.1
Giatromanolaki, A.2
Koukourakis, M.3
-
34
-
-
0030020644
-
An increase of B cells in the tumor-bearing state has the potential to induce anti-tumor immunity
-
Ito O, Harada M, Takenoyama M, et al. An increase of B cells in the tumor-bearing state has the potential to induce anti-tumor immunity. Immunobiology 1996; 195:1–15.
-
(1996)
Immunobiology
, vol.195
, pp. 1-15
-
-
Ito, O.1
Harada, M.2
Takenoyama, M.3
-
35
-
-
84893203731
-
Tumor infiltrating B-cells are increased in prostate cancer tissue
-
Woo JR, Liss MA, Muldong MT, et al. Tumor infiltrating B-cells are increased in prostate cancer tissue. J Transl Med 2014; 12:30
-
(2014)
J Transl Med
, vol.12
, pp. 30
-
-
Woo, J.R.1
Liss, M.A.2
Muldong, M.T.3
-
36
-
-
84883244497
-
Tumor-infiltrating B cells and T cells: working together to promote patient survival
-
Nielsen JS, Nelson BH. Tumor-infiltrating B cells and T cells: working together to promote patient survival. Oncoimmunology 2012; 1:1623–5.
-
(2012)
Oncoimmunology
, vol.1
, pp. 1623-1625
-
-
Nielsen, J.S.1
Nelson, B.H.2
-
37
-
-
78149488860
-
CD20+ B cells: the other tumor-infiltrating lymphocytes
-
Nelson BH. CD20+ B cells: the other tumor-infiltrating lymphocytes. J Immunol 2010; 185:4977–82.
-
(2010)
J Immunol
, vol.185
, pp. 4977-4982
-
-
Nelson, B.H.1
-
38
-
-
80053065912
-
Cytoplasmic Ig alpha serine/threonines fine-tune Ig alpha tyrosine phosphorylation and limit bone marrow plasma cell formation
-
Patterson HC, Kraus M, Wang D, et al. Cytoplasmic Ig alpha serine/threonines fine-tune Ig alpha tyrosine phosphorylation and limit bone marrow plasma cell formation. J Immunol 2011; 187:2853–8.
-
(2011)
J Immunol
, vol.187
, pp. 2853-2858
-
-
Patterson, H.C.1
Kraus, M.2
Wang, D.3
-
39
-
-
79956131523
-
Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4(+) T cells to T-regulatory cells
-
Olkhanud PB, Damdinsuren B, Bodogai M, et al. Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4(+) T cells to T-regulatory cells. Cancer Res 2011; 71:3505–15.
-
(2011)
Cancer Res
, vol.71
, pp. 3505-3515
-
-
Olkhanud, P.B.1
Damdinsuren, B.2
Bodogai, M.3
-
40
-
-
0031863680
-
B cells inhibit induction of T cell-dependent tumor immunity
-
Qin Z, Richter G, Schuler T, et al. B cells inhibit induction of T cell-dependent tumor immunity. Nat Med 1998; 4:627–30.
-
(1998)
Nat Med
, vol.4
, pp. 627-630
-
-
Qin, Z.1
Richter, G.2
Schuler, T.3
-
41
-
-
84891489921
-
B cell regulation of anti-tumor immune response
-
Zhang Y, Morgan R, Podack ER, et al. B cell regulation of anti-tumor immune response. Immunol Res 2013; 57:115–24.
-
(2013)
Immunol Res
, vol.57
, pp. 115-124
-
-
Zhang, Y.1
Morgan, R.2
Podack, E.R.3
-
42
-
-
0034698829
-
B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation
-
Moulin V, Andris F, Thielemans K, et al. B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J Exp Med 2000; 192:475–82.
-
(2000)
J Exp Med
, vol.192
, pp. 475-482
-
-
Moulin, V.1
Andris, F.2
Thielemans, K.3
-
43
-
-
84890115384
-
Role of tumor-infiltrating CD11b+ antigen-presenting cells in the progression of gastric cancer
-
Okita Y, Tanaka H, Ohira M, et al. Role of tumor-infiltrating CD11b+ antigen-presenting cells in the progression of gastric cancer. J Surg Res 2014; 186:192–200.
-
(2014)
J Surg Res
, vol.186
, pp. 192-200
-
-
Okita, Y.1
Tanaka, H.2
Ohira, M.3
-
44
-
-
33846933459
-
L-arginine availability regulates T-lymphocyte cell-cycle progression
-
Rodriguez PC, Quiceno DG, Ochoa AC. L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood 2007; 109:1568–73.
-
(2007)
Blood
, vol.109
, pp. 1568-1573
-
-
Rodriguez, P.C.1
Quiceno, D.G.2
Ochoa, A.C.3
-
45
-
-
84896723873
-
Cutting edge: FYCO1 recruitment to dectin-1 phagosomes is accelerated by light chain 3 protein and regulates phagosome maturation and reactive oxygen production
-
Ma J, Becker C, Reyes C, et al. Cutting edge: FYCO1 recruitment to dectin-1 phagosomes is accelerated by light chain 3 protein and regulates phagosome maturation and reactive oxygen production. J Immunol 2014; 192:1356–60.
-
(2014)
J Immunol
, vol.192
, pp. 1356-1360
-
-
Ma, J.1
Becker, C.2
Reyes, C.3
-
46
-
-
17244367828
-
Reactive oxygen species in tumor progression
-
Storz P. Reactive oxygen species in tumor progression. Front Biosci 2005; 10:1881–96.
-
(2005)
Front Biosci
, vol.10
, pp. 1881-1896
-
-
Storz, P.1
-
47
-
-
0035294392
-
Suppressed T-cell receptor zeta chain expression and cytokine production in pancreatic cancer patients
-
Schmielau J, Nalesnik MA, Finn OJ. Suppressed T-cell receptor zeta chain expression and cytokine production in pancreatic cancer patients. Clin Cancer Res 2001; 7:933s–9s.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 933s-939s
-
-
Schmielau, J.1
Nalesnik, M.A.2
Finn, O.J.3
-
48
-
-
0027056895
-
Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice
-
Mizoguchi H, O'Shea JJ, Longo DL, et al. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 1992; 258:1795–8.
-
(1992)
Science
, vol.258
, pp. 1795-1798
-
-
Mizoguchi, H.1
O'Shea, J.J.2
Longo, D.L.3
-
49
-
-
84906834647
-
Dok1 and Dok2 proteins regulate natural killer cell development and function
-
Celis-Gutierrez J, Boyron M, Walzer T, et al. Dok1 and Dok2 proteins regulate natural killer cell development and function. Embo J 2014; 33:1928–40.
-
(2014)
Embo J
, vol.33
, pp. 1928-1940
-
-
Celis-Gutierrez, J.1
Boyron, M.2
Walzer, T.3
|